Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
 Back to Profile

Steven Rosenberg

Concepts (590)

Concepts are derived automatically from a person's publications.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Antigens, Neoplasm
56
2025
308
13.700
 Why?
Lymphocytes, Tumor-Infiltrating
61
2025
210
13.480
 Why?
Receptors, Antigen, T-Cell
55
2024
699
11.360
 Why?
Immunotherapy, Adoptive
53
2024
295
11.130
 Why?
T-Lymphocytes
47
2024
1921
7.670
 Why?
Melanoma
49
2024
722
7.420
 Why?
Neoplasms
35
2025
2460
5.760
 Why?
CD8-Positive T-Lymphocytes
26
2023
840
4.080
 Why?
Gastrointestinal Neoplasms
7
2020
72
3.740
 Why?
Autism Spectrum Disorder
22
2024
385
3.670
 Why?
Immunotherapy
16
2025
586
3.350
 Why?
Adoptive Transfer
18
2024
215
2.830
 Why?
Proto-Oncogene Proteins p21(ras)
8
2022
258
2.760
 Why?
Mutation
32
2025
3682
2.520
 Why?
Developmental Disabilities
13
2023
258
2.510
 Why?
Cancer Vaccines
8
2021
163
2.190
 Why?
Antigens, CD19
9
2022
113
2.130
 Why?
CD4-Positive T-Lymphocytes
12
2022
1043
2.000
 Why?
Skin Neoplasms
13
2020
818
1.890
 Why?
Neoplasm Metastasis
18
2024
608
1.870
 Why?
Autistic Disorder
8
2024
185
1.810
 Why?
Programmed Cell Death 1 Receptor
8
2019
226
1.800
 Why?
Interleukin-2
6
2020
434
1.670
 Why?
Humans
191
2025
128019
1.580
 Why?
ras Proteins
4
2021
144
1.490
 Why?
Colorectal Neoplasms
5
2025
746
1.460
 Why?
Neoplasm Proteins
7
2019
419
1.370
 Why?
Tumor Suppressor Protein p53
6
2022
504
1.330
 Why?
High-Throughput Nucleotide Sequencing
6
2025
484
1.300
 Why?
Epitopes, T-Lymphocyte
9
2021
185
1.240
 Why?
Eligibility Determination
3
2014
63
1.230
 Why?
Genetic Therapy
8
2022
290
1.200
 Why?
Lymphoma, B-Cell
4
2020
105
1.130
 Why?
Membrane Proteins
9
2019
1105
1.130
 Why?
Female
99
2025
68016
1.090
 Why?
Glioblastoma
2
2021
323
1.080
 Why?
Proto-Oncogene Proteins B-raf
4
2019
212
1.060
 Why?
Motor Skills Disorders
4
2016
26
1.030
 Why?
Child Development
7
2024
452
0.990
 Why?
Transcriptome
4
2022
879
0.940
 Why?
Male
83
2025
62757
0.930
 Why?
Lymphoma, Large B-Cell, Diffuse
2
2017
112
0.920
 Why?
Genetic Engineering
6
2016
88
0.910
 Why?
HLA-A2 Antigen
11
2020
47
0.900
 Why?
Middle Aged
53
2025
30812
0.890
 Why?
Cell Line, Tumor
26
2021
3168
0.890
 Why?
Gene Expression Regulation, Neoplastic
7
2019
1343
0.880
 Why?
Flow Cytometry
9
2018
1140
0.840
 Why?
Precision Medicine
3
2015
384
0.840
 Why?
Ovarian Neoplasms
2
2019
487
0.820
 Why?
Tumor Microenvironment
2
2019
620
0.800
 Why?
T-Lymphocyte Subsets
5
2019
409
0.800
 Why?
Medicare Part C
2
2013
29
0.780
 Why?
Single-Cell Analysis
3
2022
270
0.770
 Why?
Coronary Artery Disease
5
2017
675
0.770
 Why?
Cell Separation
4
2019
312
0.760
 Why?
HLA-DP beta-Chains
3
2019
82
0.730
 Why?
Adult
45
2024
35176
0.730
 Why?
Interleukin-12
3
2020
118
0.720
 Why?
Receptors, Antigen
3
2015
15
0.700
 Why?
Hematopoietic Stem Cell Transplantation
3
2022
573
0.680
 Why?
Cognition Disorders
2
2016
497
0.680
 Why?
HLA-A Antigens
2
2021
53
0.670
 Why?
Receptors, Antigen, T-Cell, alpha-beta
4
2020
334
0.670
 Why?
Antigen Presentation
8
2020
205
0.660
 Why?
Retroviridae
2
2022
97
0.650
 Why?
Mutation, Missense
2
2020
315
0.650
 Why?
Interleukin-15
2
2017
82
0.650
 Why?
Colonic Neoplasms
2
2019
242
0.640
 Why?
Mucin-4
1
2019
4
0.630
 Why?
Smad5 Protein
1
2019
8
0.630
 Why?
Child, Preschool
29
2024
10378
0.630
 Why?
Aged
32
2025
21892
0.630
 Why?
Exome
7
2016
220
0.620
 Why?
Temperament
1
2019
47
0.620
 Why?
Cholangiocarcinoma
2
2023
77
0.620
 Why?
Lymphocyte Depletion
2
2016
129
0.620
 Why?
Immunity, Cellular
1
2020
263
0.610
 Why?
T-Lymphocytes, Regulatory
2
2019
366
0.610
 Why?
Bile Duct Neoplasms
2
2023
99
0.610
 Why?
Sequence Analysis, DNA
2
2021
771
0.590
 Why?
ErbB Receptors
2
2019
601
0.580
 Why?
RNA, Messenger
3
2020
2669
0.560
 Why?
Disease Susceptibility
1
2019
331
0.550
 Why?
Genetic Vectors
5
2022
311
0.550
 Why?
Family Characteristics
2
2018
178
0.550
 Why?
History, 20th Century
4
2025
285
0.540
 Why?
Antigens
1
2019
353
0.540
 Why?
Child Behavior
1
2019
235
0.540
 Why?
History, 21st Century
3
2025
177
0.530
 Why?
Social Behavior
2
2023
286
0.530
 Why?
Disabled Children
2
2014
66
0.520
 Why?
Awards and Prizes
1
2017
60
0.520
 Why?
Myocardial Perfusion Imaging
2
2013
36
0.520
 Why?
Communication
2
2023
838
0.520
 Why?
Transposases
1
2016
16
0.510
 Why?
Cell Engineering
1
2016
9
0.510
 Why?
Gene Expression Profiling
8
2019
1681
0.500
 Why?
Lymphoma
1
2017
194
0.500
 Why?
Self-Injurious Behavior
4
2018
120
0.500
 Why?
Psychotherapy
1
2017
155
0.490
 Why?
Bile Ducts, Intrahepatic
2
2023
65
0.490
 Why?
Cell Cycle Checkpoints
1
2016
95
0.490
 Why?
Immunologic Memory
5
2024
341
0.480
 Why?
Surveys and Questionnaires
9
2024
5353
0.470
 Why?
Breast Neoplasms
3
2022
2131
0.450
 Why?
Lymphocytes
1
2016
367
0.440
 Why?
T-Cell Antigen Receptor Specificity
7
2020
51
0.440
 Why?
Lymphocyte Transfusion
1
2013
20
0.430
 Why?
Lymphocyte Activation
10
2020
1096
0.430
 Why?
Indoles
1
2016
371
0.430
 Why?
Sentinel Lymph Node Biopsy
1
2014
107
0.430
 Why?
Th1 Cells
1
2014
136
0.420
 Why?
Vidarabine
4
2017
30
0.420
 Why?
Animals
29
2024
34487
0.420
 Why?
Plaque, Atherosclerotic
1
2014
54
0.420
 Why?
Leukemia
2
2016
228
0.420
 Why?
Histocompatibility Antigens Class I
5
2021
196
0.410
 Why?
Child
22
2024
20636
0.410
 Why?
Lymph Node Excision
1
2014
164
0.410
 Why?
Transplantation Conditioning
4
2019
165
0.410
 Why?
Sulfonamides
1
2016
494
0.400
 Why?
Cyclophosphamide
4
2017
227
0.400
 Why?
Melanoma, Experimental
4
2020
108
0.400
 Why?
Mice
21
2024
16574
0.390
 Why?
Stem Cell Transplantation
1
2013
165
0.390
 Why?
Cell- and Tissue-Based Therapy
3
2019
74
0.390
 Why?
Transfection
1
2014
891
0.390
 Why?
Genes, T-Cell Receptor
3
2022
9
0.380
 Why?
Antibodies, Monoclonal
3
2017
1354
0.370
 Why?
Adaptor Proteins, Signal Transducing
1
2014
391
0.370
 Why?
Melanoma-Specific Antigens
3
2016
5
0.360
 Why?
Biomarkers, Tumor
6
2019
1175
0.360
 Why?
Treatment Outcome
15
2021
10110
0.360
 Why?
Case-Control Studies
13
2024
3324
0.350
 Why?
United States
16
2025
13785
0.350
 Why?
Lung Neoplasms
3
2022
2327
0.350
 Why?
Neoplasms, Second Primary
2
2022
106
0.350
 Why?
Transplantation, Autologous
3
2022
211
0.340
 Why?
Coculture Techniques
3
2021
225
0.340
 Why?
Receptor, ErbB-2
4
2016
325
0.340
 Why?
Papillomavirus Infections
3
2018
290
0.340
 Why?
Papillomaviridae
3
2019
113
0.340
 Why?
Kidney Neoplasms
1
2014
349
0.330
 Why?
gp100 Melanoma Antigen
5
2016
8
0.330
 Why?
Medicaid
1
2014
433
0.330
 Why?
Infant
11
2017
8912
0.330
 Why?
Child Development Disorders, Pervasive
2
2024
61
0.330
 Why?
Coronary Angiography
4
2017
306
0.330
 Why?
Transduction, Genetic
4
2019
128
0.310
 Why?
Peptides
4
2020
910
0.310
 Why?
Combined Modality Therapy
5
2021
1199
0.310
 Why?
Human papillomavirus 16
3
2018
33
0.300
 Why?
Phenotype
6
2024
3039
0.300
 Why?
Gene Expression
6
2016
1454
0.300
 Why?
Repressor Proteins
3
2017
399
0.290
 Why?
Intellectual Disability
3
2024
149
0.290
 Why?
Antigens, Differentiation, T-Lymphocyte
2
2020
87
0.290
 Why?
Tumor Necrosis Factor Receptor Superfamily, Member 9
3
2017
25
0.280
 Why?
Cells, Cultured
8
2021
4006
0.280
 Why?
Prevalence
8
2018
2541
0.280
 Why?
Algorithms
3
2015
1609
0.280
 Why?
Prospective Studies
6
2023
7035
0.270
 Why?
Carcinoma, Squamous Cell
3
2017
620
0.270
 Why?
Neoplasm Staging
5
2018
1288
0.270
 Why?
Dendritic Cells
4
2019
475
0.270
 Why?
Tomography, X-Ray Computed
6
2018
2509
0.270
 Why?
Uterine Cervical Neoplasms
4
2018
232
0.270
 Why?
Young Adult
13
2020
12281
0.260
 Why?
Oncogene Proteins, Viral
2
2017
22
0.260
 Why?
Antineoplastic Combined Chemotherapy Protocols
2
2014
1558
0.260
 Why?
Lymphocyte Count
2
2016
150
0.260
 Why?
Cell Proliferation
8
2019
2337
0.260
 Why?
Antigens, CD
3
2020
481
0.260
 Why?
CD8 Antigens
2
2018
76
0.250
 Why?
Carcinoma
2
2018
215
0.240
 Why?
National Cancer Institute (U.S.)
1
2025
43
0.240
 Why?
Brain Neoplasms
4
2018
1163
0.240
 Why?
Tumor Cells, Cultured
5
2018
930
0.240
 Why?
Whole-Body Irradiation
2
2016
75
0.230
 Why?
Socioeconomic Factors
3
2018
1211
0.230
 Why?
Longitudinal Studies
5
2016
2706
0.230
 Why?
Adolescent
13
2023
20158
0.230
 Why?
DNA Transposable Elements
2
2016
118
0.230
 Why?
T-Lymphocytes, Cytotoxic
2
2015
168
0.220
 Why?
Sensitivity and Specificity
3
2018
1813
0.220
 Why?
Pilot Projects
4
2019
1559
0.220
 Why?
Jaundice, Neonatal
1
2023
9
0.220
 Why?
Immunohistochemistry
4
2016
1663
0.210
 Why?
Disability Evaluation
3
2014
285
0.210
 Why?
Leukocytes, Mononuclear
3
2015
539
0.210
 Why?
Infant, Very Low Birth Weight
2
2014
67
0.210
 Why?
Protein Engineering
2
2014
105
0.210
 Why?
Problem Behavior
2
2022
92
0.210
 Why?
Parks, Recreational
1
2022
10
0.200
 Why?
Proto-Oncogene Proteins
2
2017
632
0.200
 Why?
Constriction, Pathologic
2
2014
228
0.200
 Why?
Time-to-Treatment
1
2024
178
0.200
 Why?
Occupational Therapy
2
2014
85
0.190
 Why?
DNA-Binding Proteins
3
2019
1421
0.190
 Why?
Multiple Myeloma
1
2023
125
0.190
 Why?
Proteasome Endopeptidase Complex
2
2020
145
0.190
 Why?
HEK293 Cells
5
2017
681
0.190
 Why?
Adaptation, Psychological
2
2024
616
0.190
 Why?
Burkitt Lymphoma
1
2022
56
0.190
 Why?
Amino Acid Sequence
4
2020
2042
0.190
 Why?
Clone Cells
2
2019
255
0.190
 Why?
Sex Factors
4
2017
1942
0.190
 Why?
Oncogenes
2
2020
109
0.190
 Why?
Genes, Tumor Suppressor
2
2019
86
0.180
 Why?
Pancreatic Neoplasms
2
2022
873
0.180
 Why?
Genes, T-Cell Receptor alpha
1
2021
12
0.180
 Why?
Apyrase
1
2020
16
0.180
 Why?
Demography
3
2018
278
0.180
 Why?
Gene Expression Regulation
3
2019
2508
0.180
 Why?
Cytokines
6
2022
1984
0.180
 Why?
Lectins, C-Type
1
2020
69
0.180
 Why?
Epitope Mapping
2
2018
57
0.180
 Why?
Oncolytic Virotherapy
1
2020
13
0.180
 Why?
HLA Antigens
2
2021
234
0.170
 Why?
MART-1 Antigen
3
2014
12
0.170
 Why?
Physical Therapy Modalities
2
2014
292
0.170
 Why?
Psychotropic Drugs
1
2021
67
0.170
 Why?
Lymphatic Metastasis
2
2019
317
0.170
 Why?
Mice, Mutant Strains
1
2020
292
0.170
 Why?
Models, Immunological
1
2020
93
0.170
 Why?
Premature Birth
1
2023
310
0.170
 Why?
Drug Utilization
1
2021
166
0.170
 Why?
Virus Replication
1
2022
444
0.170
 Why?
HLA-C Antigens
2
2020
35
0.170
 Why?
Protein Binding
8
2020
2105
0.170
 Why?
Metastasectomy
2
2017
19
0.170
 Why?
Remission Induction
5
2020
267
0.160
 Why?
Neoplasm Recurrence, Local
2
2017
955
0.160
 Why?
Amino Acid Substitution
1
2020
280
0.160
 Why?
Gene Regulatory Networks
1
2022
279
0.160
 Why?
Age Factors
3
2024
3100
0.160
 Why?
Cysteine
1
2020
182
0.160
 Why?
Alcohol Oxidoreductases
1
2019
48
0.160
 Why?
Practice Patterns, Physicians'
2
2021
1260
0.160
 Why?
Gestational Age
2
2024
868
0.150
 Why?
Neoplasms, Glandular and Epithelial
1
2019
35
0.150
 Why?
Referral and Consultation
4
2023
724
0.150
 Why?
Follow-Up Studies
6
2020
4853
0.150
 Why?
Area Under Curve
3
2014
288
0.150
 Why?
Cell Line
4
2022
2736
0.150
 Why?
Behavior Therapy
1
2021
236
0.150
 Why?
Cohort Studies
6
2016
5378
0.150
 Why?
Neoplastic Cells, Circulating
1
2019
70
0.150
 Why?
B-Lymphocytes
3
2020
812
0.150
 Why?
Medical Oncology
1
2020
271
0.150
 Why?
Smoking
2
2018
1459
0.150
 Why?
RGS Proteins
1
2018
14
0.150
 Why?
Trees
1
2018
68
0.150
 Why?
Ubiquitin Thiolesterase
1
2018
42
0.150
 Why?
Forkhead Transcription Factors
1
2019
181
0.150
 Why?
Mothers
1
2024
729
0.150
 Why?
Education, Special
1
2017
24
0.140
 Why?
Parents
4
2022
1303
0.140
 Why?
Lymphoma, Non-Hodgkin
1
2018
76
0.140
 Why?
Psychometrics
2
2019
679
0.140
 Why?
Hematologic Neoplasms
1
2019
140
0.140
 Why?
Uveal Neoplasms
1
2017
10
0.140
 Why?
Tumor Necrosis Factor Ligand Superfamily Member 14
1
2017
4
0.140
 Why?
Self-Examination
1
2017
2
0.140
 Why?
ROC Curve
3
2013
500
0.140
 Why?
Signal Transduction
5
2019
4812
0.140
 Why?
Recombinant Fusion Proteins
3
2015
634
0.140
 Why?
Interferon-gamma
5
2020
760
0.140
 Why?
Population Surveillance
2
2017
426
0.140
 Why?
Societies, Scientific
1
2017
45
0.140
 Why?
Maternal Age
1
2017
123
0.140
 Why?
Extracellular Signal-Regulated MAP Kinases
1
2017
163
0.140
 Why?
Immunologic Surveillance
1
2017
26
0.140
 Why?
Tissue and Organ Procurement
1
2020
288
0.130
 Why?
Administration, Intravenous
1
2017
137
0.130
 Why?
Carcinogenesis
1
2018
209
0.130
 Why?
Prognosis
5
2020
3766
0.130
 Why?
Disease Progression
5
2017
2598
0.130
 Why?
Biomarkers
2
2019
3874
0.130
 Why?
CTLA-4 Antigen
1
2017
87
0.130
 Why?
fas Receptor
2
2015
95
0.130
 Why?
Sialadenitis
1
2016
2
0.130
 Why?
Antineoplastic Agents
2
2017
2041
0.130
 Why?
Logistic Models
4
2016
1975
0.130
 Why?
Peptidomimetics
1
2016
3
0.130
 Why?
Circulating Tumor DNA
1
2016
28
0.130
 Why?
WT1 Proteins
1
2016
14
0.130
 Why?
Green Fluorescent Proteins
2
2015
380
0.130
 Why?
Mitogen-Activated Protein Kinases
1
2017
311
0.130
 Why?
Urinary Bladder Neoplasms
1
2019
226
0.130
 Why?
Coronary Vessels
2
2017
236
0.130
 Why?
HLA-DQ beta-Chains
1
2016
61
0.130
 Why?
Proto-Oncogene Proteins c-akt
2
2015
419
0.130
 Why?
ras GTPase-Activating Proteins
1
2015
15
0.130
 Why?
Peer Group
1
2018
224
0.130
 Why?
Immunoglobulin M
1
2017
272
0.130
 Why?
Clonal Evolution
1
2016
38
0.130
 Why?
Immunoglobulin A
1
2017
200
0.130
 Why?
Transplantation Chimera
1
2016
54
0.130
 Why?
Immunodominant Epitopes
1
2015
28
0.130
 Why?
Molecular Targeted Therapy
1
2019
384
0.130
 Why?
Psychoanalytic Therapy
1
1995
10
0.120
 Why?
Cesarean Section
1
2017
182
0.120
 Why?
T-Lymphocytes, Helper-Inducer
1
2016
135
0.120
 Why?
RNA, Neoplasm
1
2015
87
0.120
 Why?
Epitopes
2
2015
466
0.120
 Why?
Receptors, HIV
1
2015
26
0.120
 Why?
Leukemia, Lymphocytic, Chronic, B-Cell
1
2016
63
0.120
 Why?
Zinc Fingers
1
2015
43
0.120
 Why?
Psychotherapy, Brief
1
1995
31
0.120
 Why?
Neoplasms, Germ Cell and Embryonal
1
2016
67
0.120
 Why?
Language
1
2018
280
0.120
 Why?
Sarcoma, Synovial
1
2014
16
0.120
 Why?
Immunophenotyping
1
2016
309
0.120
 Why?
Odds Ratio
2
2014
1018
0.120
 Why?
Immunity, Active
1
2014
10
0.120
 Why?
Alphapapillomavirus
1
2015
40
0.120
 Why?
Psychotherapy, Group
1
1995
64
0.120
 Why?
Receptor-Like Protein Tyrosine Phosphatases, Class 2
1
2014
10
0.120
 Why?
Endoribonucleases
1
2015
70
0.120
 Why?
Clinical Trials as Topic
5
2020
997
0.120
 Why?
Aspirin
1
2018
377
0.120
 Why?
Metalloproteins
1
2014
6
0.110
 Why?
Managed Care Programs
1
1995
133
0.110
 Why?
Triple Negative Breast Neoplasms
1
2017
191
0.110
 Why?
Clinical Trials, Phase II as Topic
1
2014
72
0.110
 Why?
Hepatitis A Virus Cellular Receptor 2
1
2014
29
0.110
 Why?
5' Untranslated Regions
1
2014
55
0.110
 Why?
Nitric Oxide Synthase Type I
1
2014
28
0.110
 Why?
Thrombotic Microangiopathies
1
2014
15
0.110
 Why?
Echocardiography, Stress
1
2013
20
0.110
 Why?
Ribosomal Proteins
1
2014
77
0.110
 Why?
Transcription Factors
2
2019
1628
0.110
 Why?
MAP Kinase Kinase Kinase 5
1
2013
3
0.110
 Why?
Tumor Lysis Syndrome
1
2013
8
0.110
 Why?
Mice, Transgenic
5
2020
2066
0.110
 Why?
Autografts
1
2013
42
0.110
 Why?
Thioredoxins
1
2013
28
0.110
 Why?
Policy Making
1
2014
87
0.110
 Why?
HLA-DR4 Antigen
1
2013
78
0.110
 Why?
Cross-Sectional Studies
5
2017
5034
0.110
 Why?
Testis
1
2014
144
0.110
 Why?
Carcinoma, Non-Small-Cell Lung
1
2022
1045
0.110
 Why?
Cognition
2
2023
1104
0.110
 Why?
Motor Skills
1
2014
90
0.100
 Why?
Extremities
1
2014
128
0.100
 Why?
Health Care Reform
1
2014
98
0.100
 Why?
Immunoglobulin G
1
2017
842
0.100
 Why?
Transcriptional Activation
1
2015
355
0.100
 Why?
Histones
1
2018
585
0.100
 Why?
Allografts
1
2013
136
0.100
 Why?
Astrocytoma
1
2013
120
0.100
 Why?
Nuclear Proteins
2
2015
657
0.100
 Why?
Psychiatric Status Rating Scales
1
2015
520
0.100
 Why?
Gene Expression Regulation, Enzymologic
1
2014
281
0.100
 Why?
Interferon-alpha
1
2014
192
0.100
 Why?
Cell Movement
4
2019
933
0.100
 Why?
Radiation Injuries
1
2014
135
0.100
 Why?
Likelihood Functions
1
2013
135
0.100
 Why?
Infant, Newborn
4
2023
5688
0.100
 Why?
Nanotechnology
1
2013
119
0.100
 Why?
Esophageal Neoplasms
1
2016
293
0.100
 Why?
Risk Factors
5
2023
9696
0.100
 Why?
Survival Rate
4
2020
1870
0.100
 Why?
Receptors, N-Methyl-D-Aspartate
1
2014
200
0.100
 Why?
Proto-Oncogene Proteins c-bcl-2
1
2013
228
0.100
 Why?
Sarcoma
1
2014
176
0.100
 Why?
Calcinosis
1
2014
230
0.090
 Why?
Muscle Proteins
1
2013
221
0.090
 Why?
Propensity Score
1
2013
264
0.090
 Why?
Cost of Illness
1
2014
277
0.090
 Why?
Killer Cells, Natural
1
2014
426
0.090
 Why?
Anxiety
1
2018
951
0.090
 Why?
Randomized Controlled Trials as Topic
2
2013
1356
0.090
 Why?
Research Design
2
2014
1034
0.090
 Why?
Wounds and Injuries
1
2018
705
0.090
 Why?
Genome, Human
1
2013
390
0.090
 Why?
Head and Neck Neoplasms
1
2016
532
0.090
 Why?
Health Policy
1
2014
351
0.090
 Why?
Xenograft Model Antitumor Assays
3
2020
809
0.090
 Why?
RNA-Binding Proteins
1
2014
388
0.090
 Why?
Exercise Test
1
2013
613
0.090
 Why?
Cytotoxicity, Immunologic
3
2016
216
0.090
 Why?
Genetic Testing
1
2013
428
0.080
 Why?
Reverse Transcriptase Polymerase Chain Reaction
4
2014
940
0.080
 Why?
Decision Support Techniques
1
2013
396
0.080
 Why?
Time Factors
2
2017
6479
0.080
 Why?
Models, Theoretical
1
2013
541
0.080
 Why?
K562 Cells
2
2020
82
0.080
 Why?
Databases, Factual
3
2023
1264
0.080
 Why?
HIV-1
1
2015
833
0.080
 Why?
Adenocarcinoma
1
2016
888
0.080
 Why?
Colorado
2
2017
4369
0.080
 Why?
Protein Kinase Inhibitors
1
2014
875
0.080
 Why?
Coronary Stenosis
1
2008
39
0.080
 Why?
Anti-HIV Agents
1
2015
749
0.080
 Why?
Arthritis, Rheumatoid
1
2017
1088
0.080
 Why?
Comorbidity
3
2018
1537
0.070
 Why?
Double-Blind Method
1
2013
1852
0.070
 Why?
Risk Assessment
2
2014
3223
0.070
 Why?
Apoptosis
2
2013
2425
0.070
 Why?
Neutrophils
1
2013
1192
0.070
 Why?
RNA, Small Interfering
3
2014
569
0.070
 Why?
Neoplasm Transplantation
3
2015
257
0.070
 Why?
Protective Factors
2
2017
91
0.070
 Why?
Mass Screening
2
2020
1145
0.070
 Why?
Faculty
1
2007
135
0.060
 Why?
Cross Reactions
2
2016
129
0.060
 Why?
DNA Mutational Analysis
2
2019
384
0.060
 Why?
Mice, Inbred C57BL
4
2020
5268
0.060
 Why?
Cardiovascular Diseases
1
2018
1994
0.060
 Why?
Molecular Sequence Data
3
2015
2820
0.060
 Why?
CD4 Antigens
2
2016
138
0.060
 Why?
Neutropenia
2
2017
134
0.060
 Why?
Retrospective Studies
5
2024
14404
0.060
 Why?
Mice, Inbred NOD
2
2018
586
0.060
 Why?
Single-Chain Antibodies
2
2015
16
0.060
 Why?
Protein Transport
2
2017
420
0.060
 Why?
Intercellular Junctions
2
2014
39
0.060
 Why?
Physical Examination
2
2017
230
0.060
 Why?
GPI-Linked Proteins
2
2014
67
0.050
 Why?
Lung
1
2016
3745
0.050
 Why?
Parity
1
2024
120
0.050
 Why?
Nerve Tissue Proteins
2
2020
569
0.050
 Why?
Receptor, Fibroblast Growth Factor, Type 2
1
2023
24
0.050
 Why?
Point Mutation
2
2014
221
0.050
 Why?
Health Facilities
1
2023
79
0.050
 Why?
Autoantigens
2
2016
416
0.050
 Why?
Real-Time Polymerase Chain Reaction
2
2013
323
0.050
 Why?
Bone Marrow
1
2023
267
0.050
 Why?
Minority Groups
1
2024
250
0.050
 Why?
Receptors, Cell Surface
1
2004
373
0.050
 Why?
Cluster Analysis
2
2014
477
0.050
 Why?
Linear Models
1
2024
816
0.050
 Why?
Alleles
2
2015
842
0.050
 Why?
Skin
2
2019
711
0.050
 Why?
Severity of Illness Index
2
2023
2703
0.050
 Why?
Oligonucleotide Array Sequence Analysis
2
2014
755
0.050
 Why?
Educational Status
1
2023
470
0.040
 Why?
Recombinant Proteins
2
2014
1286
0.040
 Why?
Proportional Hazards Models
1
2024
1194
0.040
 Why?
Parenting
1
2024
296
0.040
 Why?
Predictive Value of Tests
2
2017
1934
0.040
 Why?
Models, Genetic
2
2013
591
0.040
 Why?
Glioma
1
2004
353
0.040
 Why?
Jurkat Cells
1
2020
130
0.040
 Why?
Immunoglobulins
1
2020
157
0.040
 Why?
Base Sequence
2
2014
2134
0.040
 Why?
Cysteine Endopeptidases
1
2020
67
0.040
 Why?
Caregivers
2
2018
810
0.040
 Why?
Early Diagnosis
1
2020
234
0.040
 Why?
Cyclin-Dependent Kinase Inhibitor p16
1
2019
69
0.040
 Why?
Health Care Surveys
1
2021
556
0.040
 Why?
Hydrolysis
1
2019
184
0.040
 Why?
GTP Phosphohydrolases
1
2019
83
0.040
 Why?
Fusion Regulatory Protein 1, Heavy Chain
1
2018
2
0.040
 Why?
Protein Domains
1
2020
252
0.040
 Why?
Forests
1
2018
57
0.040
 Why?
GTP-Binding Protein alpha Subunits, Gi-Go
1
2018
17
0.040
 Why?
Cervix Uteri
1
2018
50
0.040
 Why?
Nuclear Localization Signals
1
2017
15
0.040
 Why?
Healthcare Disparities
1
2024
579
0.040
 Why?
Uterine Cervical Dysplasia
1
2018
43
0.040
 Why?
Mice, SCID
1
2018
350
0.040
 Why?
Hydrogen Bonding
1
2018
149
0.040
 Why?
Disulfides
1
2018
96
0.040
 Why?
Platelet Aggregation
1
2018
92
0.040
 Why?
Ligands
2
2013
616
0.030
 Why?
Eye Enucleation
1
2017
11
0.030
 Why?
Human papillomavirus 18
1
2017
15
0.030
 Why?
Protein Stability
1
2018
159
0.030
 Why?
Response Evaluation Criteria in Solid Tumors
1
2017
17
0.030
 Why?
GTP-Binding Protein alpha Subunits
1
2017
14
0.030
 Why?
GTP-Binding Protein alpha Subunits, Gq-G11
1
2017
18
0.030
 Why?
Culture Media, Serum-Free
1
2016
49
0.030
 Why?
Lymphopenia
1
2017
59
0.030
 Why?
Binding Sites
1
2020
1241
0.030
 Why?
Peptide Fragments
2
2015
688
0.030
 Why?
Drug Synergism
1
2017
356
0.030
 Why?
Vaccinia virus
1
2016
42
0.030
 Why?
Antigen-Presenting Cells
1
2017
150
0.030
 Why?
HLA-DRB1 Chains
1
2017
108
0.030
 Why?
Adenosine Triphosphate
1
2019
469
0.030
 Why?
Blood Chemical Analysis
1
2017
94
0.030
 Why?
Asymptomatic Diseases
1
2017
83
0.030
 Why?
Salivary Glands, Minor
1
2016
9
0.030
 Why?
Tissue Array Analysis
1
2016
57
0.030
 Why?
Health Surveys
1
2018
491
0.030
 Why?
Radiotherapy
1
2017
185
0.030
 Why?
Neoplasm Invasiveness
1
2018
477
0.030
 Why?
Machine Learning
1
2021
442
0.030
 Why?
Leukemia, B-Cell
1
2016
13
0.030
 Why?
Cell Membrane
1
2020
725
0.030
 Why?
Feasibility Studies
1
2020
860
0.030
 Why?
Palate
1
2016
33
0.030
 Why?
HLA-A1 Antigen
1
2015
4
0.030
 Why?
Fas Ligand Protein
1
2015
59
0.030
 Why?
Antigen-Antibody Reactions
1
2015
51
0.030
 Why?
Genes, erbB-2
1
2015
28
0.030
 Why?
MAP Kinase Signaling System
1
2017
304
0.030
 Why?
Health Promotion
1
2022
716
0.030
 Why?
Salvage Therapy
1
2016
133
0.030
 Why?
Anemia
1
2017
160
0.030
 Why?
Anus Neoplasms
1
2015
30
0.030
 Why?
Interferon-gamma Release Tests
1
2015
32
0.030
 Why?
Compulsive Behavior
1
2015
7
0.030
 Why?
Gastrointestinal Diseases
1
2017
196
0.030
 Why?
Necrosis
1
2016
228
0.030
 Why?
Thrombocytopenia
1
2017
184
0.030
 Why?
DNA, Neoplasm
1
2015
159
0.030
 Why?
HIV Envelope Protein gp120
1
2015
57
0.030
 Why?
Cloning, Molecular
1
2016
522
0.030
 Why?
Dermatitis
1
2014
19
0.030
 Why?
HIV Antibodies
1
2015
57
0.030
 Why?
Protein Conformation
1
2018
853
0.030
 Why?
Income
1
2016
189
0.030
 Why?
Metabolic Clearance Rate
1
2014
108
0.030
 Why?
Desmoplakins
1
2014
19
0.030
 Why?
Regression Analysis
1
2017
978
0.030
 Why?
Transplantation, Homologous
1
2016
389
0.030
 Why?
Granulocyte-Macrophage Colony-Stimulating Factor
1
2015
146
0.030
 Why?
Models, Statistical
1
2018
621
0.030
 Why?
Monophenol Monooxygenase
1
2014
7
0.030
 Why?
Cell Survival
1
2017
1073
0.030
 Why?
Nausea
1
2014
108
0.030
 Why?
Comparative Genomic Hybridization
1
2014
32
0.030
 Why?
Gene Library
1
2014
115
0.030
 Why?
Mice, Inbred BALB C
1
2017
1227
0.030
 Why?
Sleep Wake Disorders
1
2017
248
0.030
 Why?
National Institutes of Health (U.S.)
1
2014
122
0.030
 Why?
Random Allocation
1
2014
342
0.030
 Why?
MAP Kinase Kinase 4
1
2013
28
0.030
 Why?
Social Class
1
2016
258
0.030
 Why?
Infusions, Intravenous
1
2014
390
0.030
 Why?
Substrate Specificity
1
2014
366
0.030
 Why?
Histocompatibility Antigens
1
2014
107
0.030
 Why?
Graft vs Host Disease
1
2016
238
0.030
 Why?
Tumor Burden
1
2014
283
0.030
 Why?
Health Services Accessibility
1
2021
895
0.030
 Why?
X-Ray Diffraction
1
2013
94
0.030
 Why?
Lentivirus
1
2013
52
0.030
 Why?
Radiotherapy, Adjuvant
1
2014
209
0.030
 Why?
Confidence Intervals
1
2014
316
0.030
 Why?
Structure-Activity Relationship
1
2014
538
0.030
 Why?
Immunoenzyme Techniques
1
2013
205
0.030
 Why?
Fever
1
2014
295
0.030
 Why?
Immunoprecipitation
1
2013
157
0.030
 Why?
Reproducibility of Results
2
2012
3009
0.030
 Why?
Models, Molecular
1
2018
1482
0.030
 Why?
Bias
1
2013
196
0.030
 Why?
Drug Administration Schedule
1
2014
755
0.030
 Why?
Cost-Benefit Analysis
1
1995
567
0.020
 Why?
Histocompatibility Antigens Class II
1
2014
360
0.020
 Why?
DNA Primers
1
2013
509
0.020
 Why?
Cotinine
1
2012
75
0.020
 Why?
Receptors, Immunologic
1
2013
215
0.020
 Why?
Spleen
1
2014
507
0.020
 Why?
Liver Neoplasms
1
2017
633
0.020
 Why?
Bayes Theorem
1
2013
369
0.020
 Why?
Pregnancy
1
2023
6355
0.020
 Why?
Blotting, Western
1
2013
1169
0.020
 Why?
Carrier Proteins
1
2014
730
0.020
 Why?
Multivariate Analysis
1
2014
1492
0.020
 Why?
Dose-Response Relationship, Drug
1
2014
1943
0.020
 Why?
Aged, 80 and over
2
2014
7029
0.020
 Why?
Kinetics
1
2013
1617
0.020
 Why?
Tumor Necrosis Factor-alpha
1
2015
1185
0.020
 Why?
Phosphorylation
1
2014
1681
0.020
 Why?
Infant, Premature
1
2014
536
0.020
 Why?
North Carolina
1
2008
98
0.020
 Why?
Germany
1
2008
97
0.020
 Why?
Self Report
1
2012
796
0.020
 Why?
Cell Differentiation
1
2015
1896
0.020
 Why?
Education of Intellectually Disabled
1
1987
3
0.020
 Why?
Disease Models, Animal
1
2018
3936
0.020
 Why?
Vaccination
1
2016
1343
0.020
 Why?
Models, Biological
1
2014
1689
0.020
 Why?
Intelligence
1
2007
129
0.020
 Why?
MicroRNAs
1
2013
674
0.020
 Why?
Polymorphism, Single Nucleotide
1
2013
2059
0.020
 Why?
Receptors, Urokinase Plasminogen Activator
1
2004
14
0.010
 Why?
Urokinase-Type Plasminogen Activator
1
2004
29
0.010
 Why?
Transplantation, Heterologous
1
2004
187
0.010
 Why?
Species Specificity
1
2004
568
0.010
 Why?
Mice, Nude
1
2004
675
0.010
 Why?
Neovascularization, Pathologic
1
2004
289
0.010
 Why?
Down Syndrome
1
1987
469
0.010
 Why?
Polyethylene Glycols
1
2004
598
0.010
 Why?
Endothelium, Vascular
1
2004
844
0.010
 Why?
Rosenberg's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (590) concept(s)
_
Co-Authors Expand Description
See all (10) people
_
Similar People Expand Description
See all (60) people
_
Same Department Expand Description
Search Department
Physical Neighbors Expand Description
_

Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)